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Background
Left ventricular hypertrophy (LVH) is an important
marker of adverse prognosis in cardiovascular disease
and commonly occurs in association with hypertension.
While late gadolinium enhancement (LGE) reflects myo-
cardial replacement fibrosis in hypertensive patients, we
hypothesized that the myocardial extracellular volume
fraction (MECVF) would better reflect the presence and
severity of myocardial fibrosis, including diffuse fibrosis,
in hypertensive patients with LVH. We sought to mea-
sure the MECVF directly using T1 imaging pre- and
post-contrast.
Methods
We performed 3T cardiac MRI in 19 subjects including
9 normo-tensive control subjects (mean age 45±11
years, 66.7% female) and 10 patients (mean age 65±15
years, 40% female) with (1) systemic hypertension,
(2) LVH by ECG or echocardiography, (3) a LVEF ≥ 50%
and (4) no LGE. MRI included cine imaging and LGE 10
minutes after 0.15 mmol/Kg of gadolinium. In addition, a
Look-Locker gradient echo technique with adiabatic
inversion was used, once before and 3 times over a 30-
min period after gadolinium injection, to quantify T1.
The myocardial partition coefficient was estimated by
least-squares linear regression of R1 (1/T1) in myocar-
dium against R1 in blood. MECVF was obtained by
adjusting the partition coefficient by the patient ’s
hematocrit.
Results
The mean blood pressure (BP) at the time of MRI was
not significantly different in treated hypertensive
patients compared with control subjects (mean systolic
BP 128 vs. 118 mmHg, p=0.1165; mean diastolic BP 69
vs. 74 mmHg, p=0.2930). Despite the presence of LVH
by ECG or echocardiography, the median LV mass
index by cardiac MRI only demonstrated a trend
increase (p=0.0653) in hypertensive patients (53.8 g/m2
IQR 41.3-59.2) compared to controls (44.5 g/m2 IQR
36.5-48.3). However, there was evidence of increased
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MECVF in hypertensive patients (mean 0.34±0.03 vs.
0.24±0.03 in controls, p<0.0001, figure). There was no
correlation between MECVF and LV mass index
(r=0.32, p=0.17), and between MECVF and the E/E’
ratio by tissue Doppler echocardiography in hyperten-
sive patients (n=8, r=0.24 p=0.53 for the lateral wall,
r=0.12 p=0.75 for the septal wall).
Conclusions
Patients with chronic hypertension show evidence of
extracellular matrix expansion. We postulate that our
method of direct quantification of extracellular matrix
expansion by MECVF may better reflect the impact
of increased afterload on the LV myocardium than
LV mass or echocardiographic assessment of diastolic
function. This novel quantitative method also holds pro-
mises for monitoring the effects of antihypertensive
medication.
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